GENE ONLINE|News &
Opinion
Blog

Biomarker
R&D Biomarker
Australian Researchers Discover First Biomarker for Sudden Infant Death Syndrome
2022-05-18
R&D Biomarker
Wearable Device for Measuring Multiple Biomarkers Anytime, Anywhere
2022-05-13
Asia-Pacific AI
Israeli and South Korean Companies Collaborate in Drug Innovation with Data Platform
2022-04-19
Technology Infertility
How the IHMED Reproductive Center Improves Infertility Outcomes by Targeting Immune Response
2022-04-19Partner
In-Depth AACR
AACR 2022: Roadmap to a Successful Biotech Start-up Journey
2022-04-16
Special Cancer
How Patients with dMMR/MSI-H Tumors Can Benefit from Immunotherapy?
2021-09-24
Interviews Precision Oncology
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
2021-06-02
Technology AI
Memorial Sloan Kettering AI spinout Partners with a Fortune 500 Company to Advance AI-powered Cancer Diagnosis
2021-05-28
M&A
Roche Forays into Syndromic Panel Testing by Placing $1.8 Billion Bet on GenMark Acquisition
2021-03-15
Trials & Approvals Liquid Biopsy
FDA Okays Foundation Medicine’s Comprehensive Liquid Biopsy Test
2020-08-27
Trials & Approvals
AACR Conference – Major Highlights of Immunotherapy Clinical Trials
2020-04-30
Technology
AACR 2020 Conference – Opening Clinical Plenary Highlights
2020-04-28
R&D
Gilead, Second Genome Partner to Explore Microbial Biomarkers
2020-04-08
COVID-19
QuarkBio Announces a COVID-19 Test Kit, 10 Times More Sensitive than Existing Kits
2020-03-24
In-Depth Biomarker
Things you must know about the 10-minute universal cancer test
2018-12-11
1 2
LATEST
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
AI, Smart Tech, and ICT to Unite the Global Biotech and Healthcare Industries in 2025
2024-12-06
Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator
2024-12-05
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
2024-12-05
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
Gilead Strikes Again: $415M Bet on ADCs with Tubulis Deal
2024-12-03
FDA Investigates Reports of Blood Cancer Cases Linked to Gene Therapy
2024-12-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top